Skip to content
NoBlaBlaFinance
FilingsCompaniesSectorsCalendar
Log inFrançais
Inside informationEnglish

Transgene to Provide Updated Phase I Data in a Rapid Oral Presentation on Individualized Therapeutic Cancer Vaccine TG4050 at ASCO 2025

Transgene S.A.

The file is served by the AMF. We do not host a copy.

Document type

Filed
23/04/2025, 17:45
Document type
Inside information
AMF sub-type
Informations privilégiées
Language
English
AMF reference
111819_20250423